tiprankstipranks
Rocket Pharmaceuticals (RCKT)
NASDAQ:RCKT
US Market

Rocket Pharmaceuticals (RCKT) Income Statement

Compare
1,342 Followers

Rocket Pharmaceuticals Income Statement

Last quarter (Q3 2024), Rocket Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Rocket Pharmaceuticals's net income was $-66.72M. See Rocket Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -7.10M$ -6.27M$ -5.37M$ -1.15M$ -426.00K
Operating Expenses
$ 259.66M$ 223.84M$ 166.25M$ 134.30M$ 75.90M
Depreciation and Amortization
$ 7.10M$ 6.27M$ 5.37M$ 1.15M$ 426.00K
EBITDA
$ -236.62M$ -213.69M$ -161.72M$ -131.59M$ -71.14M
Operating Income
$ -259.66M$ -224.34M$ -167.25M$ -134.30M$ -76.15M
Other Income/Expenses
$ 14.06M$ 2.48M$ -1.82M$ -5.40M$ -1.12M
Pretax Income
$ -245.59M$ -221.86M$ -169.07M$ -139.70M$ -77.27M
Net Income
$ -245.59M$ -219.38M$ -169.59M$ -146.67M$ -83.23M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.92$ -3.22$ -2.68$ -2.65$ -1.70
Diluted EPS
$ -2.92$ -3.22$ -2.68$ -2.65$ -1.70
Weighted Average Shares Outstanding
84.01M 68.15M 63.24M 55.38M 49.01M
Weighted Average Shares Outstanding (Diluted)
84.01M 68.15M 63.24M 55.38M 49.01M
Currency in USD

Rocket Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis